metoclopramide has been researched along with Adenohypophyseal Diseases in 1 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nishida, S | 1 |
| Matsuki, M | 1 |
| Horino, M | 1 |
| Kawai, Y | 1 |
| Tsushima, K | 1 |
| Yoneda, M | 1 |
| Oyama, H | 1 |
| Ishii, R | 1 |
1 other study available for metoclopramide and Adenohypophyseal Diseases
| Article | Year |
|---|---|
Dopamine-mediated effects induced by metoclopramide simultaneously on adrenocorticotropic hormone and prolactin in patients with pituitary and/or hypothalamic disorders.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Child; Dopamine; Female; Growth Hormone; Human | 1990 |